Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Atorvastatin 10 mg	257
Overall Study	STARTED	Ezetimibe 10 mg/Simvastatin 20 mg	259
Overall Study	STARTED	Atorvastatin 20 mg	259
Overall Study	STARTED	Ezetimibe 10 mg/Simvastatin 40 mg	257
Overall Study	STARTED	Atorva 40 mg	257
Overall Study	COMPLETED	Atorvastatin 10 mg	240
Overall Study	COMPLETED	Ezetimibe 10 mg/Simvastatin 20 mg	233
Overall Study	COMPLETED	Atorvastatin 20 mg	241
Overall Study	COMPLETED	Ezetimibe 10 mg/Simvastatin 40 mg	235
Overall Study	COMPLETED	Atorva 40 mg	241
Overall Study	NOT COMPLETED	Atorvastatin 10 mg	17
Overall Study	NOT COMPLETED	Ezetimibe 10 mg/Simvastatin 20 mg	26
Overall Study	NOT COMPLETED	Atorvastatin 20 mg	18
Overall Study	NOT COMPLETED	Ezetimibe 10 mg/Simvastatin 40 mg	22
Overall Study	NOT COMPLETED	Atorva 40 mg	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00535405/flow